首页|肿瘤标志物在肺癌检验与诊断中的应用价值

肿瘤标志物在肺癌检验与诊断中的应用价值

扫码查看
目的 分析肿瘤标志物在肺癌检验与诊断中的应用效能.方法 研究以88例疑似肺癌患者为实验组,选择同一时期体检健康人员88例作为对照组.对研究对象均实施血清肿瘤标志物检测,分析2组的肿瘤标志物水平.根据穿刺结果,对实验组患者进行分组,分为良性组(肺部肿瘤)、恶性组(肺癌),比较肿瘤标志物指标,同时分析单独指标以及联合检测检出结果.结果 实验组患者的各个肿瘤标志物水平均高于对照组(P<0.05).肺部恶性肿瘤患者46例,良性肿瘤患者42例,恶性组患者的肿瘤标志物水平明显高于良性患者.联合检测检出率明显高于单一检测,分别比较差异存在统计学意义(P<0.05),但是单一指标之间无差异(P>0.05).血清癌胚抗原(CEA)、癌胚抗原(CA125)、神经元特异性烯醇化酶(NESE9)、细胞角蛋白19片段21-1(CYFRA21-1)均为正相关,相关系数分布在0.859~0.926,为高度相关.结论 在肺癌诊断和检测过程中,实施肿瘤标志物检验可以有效提高肺癌检出率,同时还能区分良恶性,为临床提供科学的数据支持.
Application Value of Tumor Markers in Lung Cancer Examination and Diagnosis
Objective To analyze the application efficacy of tumor markers in the examination and diagnosis of lung cancer.Methods A total of 88 suspected lung cancer patients were selected as the experimental group,and 88 healthy individu-als undergoing physical examinations during the same period were chosen as the control group.Serum tumor marker detection was performed on all subjects,and the levels of tumor markers in the 2 groups were analyzed.According to the results of biopsy,the patients in the experimental group were divided into benign group(lung tumors)and malignant group(lung cancer),and the tumor marker indices were compared.Meanwhile,the detection results of single markers and combined detection were analyzed.Results The levels of various tumor markers in patients of the experimental group were significantly higher than those in the con-trol group(P<0.05).There were 46 lung malignant tumor patients,and 42 cases of benign lung tumors.The tumor marker data of patients in the malignant group were significantly higher than those in the benign group.The detection rate of combined detection was significantly higher than that of single detection,and the differences were statistically significant.However,there was no differ-ence between single markers(P>0.05).Carcinoembryonic antigen(CEA),cancer antigen 125(CA1 25),neuron-specific enolase(NESE9),and cytokeratin 19 fragment 21-1(CYFRA21-1)were positively correlated,with correlation coefficients ranging from 0.859 to 0.926,indicating a high correlation.Conclusion Tumor marker testing can effectively improve the detection rate of lung cancer and differentiate between benign and malignant tumors during the diagnosis and detection of lung cancer,providing scientific data support for clinical practice.

Tumor markerLung cancerDiagnostic value

宋俐君、周真珍、陈曦

展开 >

450007 河南省郑州市中医院

肿瘤标志物 肺癌 诊断价值

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(7)